Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...
BMJ2d
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
These are explained by two important differences in the design ... 3 and 4 trials in our sample was that the TMC114FD1HTX1002 trial involved a dedicated phase 1 clinical trial site, with oversight ...
The American Journal of Managed Care2d
Clinical Trials Must Represent Those Who Will Receive Therapy
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Clinical Pharmacist Answers Pharmacology Questions
The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...
How Can Clinical Trials Improve Diversity? CTM’s Cara Brant Explains
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Altimmune's Catalytic Moment In 2025: Pemvidutide's Phase 2b Trial In MASH
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...